Zbigniew Konopski
Overview
Explore the profile of Zbigniew Konopski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haukeland J, Midgard H, Konopski Z, Sarna V, Grotta O, Klow N
Tidsskr Nor Laegeforen
. 2022 Oct;
142(14).
PMID: 36226423
Background: Transjugular intrahepatic portosystemic shunt is a treatment for complications of portal hypertension, such as bleeding gastroesophageal varices and refractory ascites. In this article we reveal our experiences with this...
2.
Tjonnfjord S, Tjonnfjord E, Konopski Z, Tjonnfjord G
Case Rep Hematol
. 2021 Nov;
2021:1862446.
PMID: 34721911
Ibrutinib is a targeted therapy drug that blocks the activity of Bruton's tyrosine kinase, and it is an approved treatment for several mature B-cell malignancies including chronic lymphocytic leukaemia (CLL)....
3.
Haukeland J, Smastuen M, Palsdatter P, Ismail M, Konopski Z, Jorgensen K, et al.
PLoS One
. 2020 Mar;
15(3):e0230263.
PMID: 32163489
Background & Aims: The prognostic role of gender in patients with liver cirrhosis is not fully understood. Our primary aim was to assess how gender affects cumulative incidence and risk...
4.
Midgard H, Bjoro B, Maeland A, Konopski Z, Kileng H, Damas J, et al.
J Hepatol
. 2016 Jan;
64(5):1020-1026.
PMID: 26780289
Background & Aims: On-going risk behaviour can lead to hepatitis C virus (HCV) reinfection following successful treatment. We aimed to assess the incidence of persistent HCV reinfection in a population...
5.
Otterdal K, Haukeland J, Yndestad A, Dahl T, Holm S, Segers F, et al.
Clin Transl Gastroenterol
. 2015 Jul;
6:e95.
PMID: 26133108
Objectives: The tumor necrosis factor superfamily member 14, LIGHT (homologous to lymphotoxin, exhibits inducible expression, and competes with HSV glycoprotein D for herpes virus entry mediator (HVEM), a receptor expressed...
6.
Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Loberg E, Haukeland J
Scand J Gastroenterol
. 2012 Dec;
48(1):93-100.
PMID: 23205894
Objective: To evaluate the predictive value of transient elastography (TE), easy available biochemical scores and a combination of these to detect advanced liver fibrosis (i.e. fibrosis stage ≥F3) in patients...
7.
Haukeland J, Dahl T, Yndestad A, Gladhaug I, Loberg E, Haaland T, et al.
Eur J Endocrinol
. 2011 Dec;
166(3):503-10.
PMID: 22170794
Objective: Fetuin A has been associated with insulin resistance and the metabolic syndrome. We therefore explored the role of fetuin A in nonalcoholic fatty liver disease (NAFLD). Design: Cross-sectional and...
8.
Sloth Andersen E, Weiland O, Leutscher P, Krarup H, Westin J, Moessner B, et al.
Scand J Gastroenterol
. 2011 Mar;
46(6):760-6.
PMID: 21438780
Objective: Case reports and short-term clinical trials have suggested that treatment for chronic hepatitis B (CHB) may lead to improvement of cirrhosis. The aim of the present study was to...
9.
Dahl T, Haukeland J, Yndestad A, Ranheim T, Gladhaug I, Damas J, et al.
J Clin Endocrinol Metab
. 2010 Apr;
95(6):3039-47.
PMID: 20392873
Context: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western and non-Western countries, but its pathogenesis is not fully understood. Objective: Based on the role of...
10.
Haukeland J, Konopski Z, Eggesbo H, von Volkmann H, Raschpichler G, Bjoro K, et al.
Scand J Gastroenterol
. 2009 Oct;
44(7):853-60.
PMID: 19811343
Objective: The antidiabetic agent metformin is regularly discussed as a promising treatment for non-alcoholic fatty liver disease (NAFLD), which is characterized by insulin resistance. However, the evidence for its beneficial...